The web search results mention the Trump administration planning a pilot program and discussing delays/concerns, but no two or more independent news sources confirm the specific detail that 'federal officials said Tuesday' that the delay is due to health insurance company concerns. The evidence is primarily drawn from reports citing the administration's planning.

The web search results mention a transitional program starting in mid-2026 for Medicare Part D, but none of the provided evidence confirms the specific timeline ('July through the end of 2027') or the definitive statement that Medicare will 'foot the bill on its own' for that entire period.

The claim attributes a specific statement ('...will inform the potential implementation of BALANCE in Part D') to CMS in a memo. While CMS is referenced in relation to the program in the web results, the specific quote and memo context are not independently corroborated by multiple sources.

The web search results indicate CMS is launching pilots for Medicaid drug cost reduction, but none of the provided evidence confirms the specific deadline that states must apply by ('July 31').

Two web search results confirm that Bobby Hunter is associated with government programs at UnitedHealth, and one mentions his role. However, the specific detail that he 'cited concerns about the initiative on the company's earnings call Tuesday morning' is only supported by the context of the search results, not independently confirmed by a second source.

The web search results provide general eligibility information for Medicare (age 65+, disability, ESRD, ALS) but do not contain any definitive statement or legal text confirming that Medicare is *absolutely* barred by law from covering weight-loss drugs. The evidence is descriptive of general eligibility, not a legal prohibition.